Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuron (IMRN) Common Equity (2017 - 2025)

Immuron has reported Common Equity over the past 9 years, most recently at $5.2 million for Q2 2025.

  • Quarterly results put Common Equity at $5.2 million for Q2 2025, down 38.3% from a year ago — trailing twelve months through Jun 2025 was $5.2 million (down 38.3% YoY), and the annual figure for FY2025 was $5.2 million, down 37.26%.
  • Common Equity for Q2 2025 was $5.2 million at Immuron, down from $8.4 million in the prior quarter.
  • Over the last five years, Common Equity for IMRN hit a ceiling of $19.9 million in Q2 2021 and a floor of $5.2 million in Q2 2025.
  • Median Common Equity over the past 5 years was $13.1 million (2023), compared with a mean of $12.6 million.
  • Biggest five-year swings in Common Equity: soared 439.06% in 2021 and later plummeted 38.3% in 2025.
  • Immuron's Common Equity stood at $19.9 million in 2021, then fell by 16.75% to $16.6 million in 2022, then dropped by 21.02% to $13.1 million in 2023, then tumbled by 36.12% to $8.4 million in 2024, then crashed by 38.3% to $5.2 million in 2025.
  • The last three reported values for Common Equity were $5.2 million (Q2 2025), $8.4 million (Q2 2024), and $13.1 million (Q2 2023) per Business Quant data.